Medical devices, healthcare technology and the business of care
510(k) clearance · K261933

Voluson Expert 18; Voluson Expert 20; Voluson Expert 22

GE Medical Systems Ultrasound and Primary care Diagnostics, LLC · Decision date Oct 2, 2026

MEDTECHLEDGER EXPLANATIONK261933

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 2, 2026 for K261933, a traditional 510(k) from GE Medical Systems Ultrasound and Primary Care Diagnostics, LLC covering the Voluson Expert 18, 20 and 22 ultrasound systems. The submission was received June 9, 2026 under 21 CFR 892.1550 (ultrasonic pulsed Doppler imaging system, Class II), with primary product code IYN and subsequent codes IYO, ITX and QIH; the review specialty and panel were radiology. SESE is a clearance, not a PMA approval.

The summary names K252328, the prior Voluson Expert 18/20/22, as primary predicate and K251169 Vivid Pioneer as a reference device. Listed changes include support for Vscan Air SL and CL wireless probes, the eX7C probe described as substantially equivalent to the eM6C G3-D, and migration of the already cleared 6Sc-D probe. Model differentiation is by locked features: Expert 18 is the lower version, Expert 20 excludes the eM6C G3 and eX7C electronic probes, and Expert 22 allows all probes and functions. The documents do not give clinical performance data supporting these claims.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261933
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
Oct 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K261933 received

    Application receipt date recorded by FDA.

  2. K261933 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 16, 2026FDA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 8, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceOct 8, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GE Medical Systems Ultrasound and Primary care Diagnostics, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Waukesha, WI

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records